Equinix, Inc. Operating Cash Flow decreased by 37.3% to $717.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.4%, from $809.00M to $717.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 11.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $599.20M | $664.75M | $892.11M | $581.12M | $801.58M | $820.29M | $760.01M | $692.00M | $741.00M | $785.00M | $999.00M | $598.00M | $912.00M | $758.00M | $981.00M | $809.00M | $944.00M | $1.01B | $1.14B | $717.00M |
| QoQ Change | — | +10.9% | +34.2% | -34.9% | +37.9% | +2.3% | -7.3% | -8.9% | +7.1% | +5.9% | +27.3% | -40.1% | +52.5% | -16.9% | +29.4% | -17.5% | +16.7% | +7.4% | +12.8% | -37.3% |
| YoY Change | — | — | — | — | +33.8% | +23.4% | -14.8% | +19.1% | -7.6% | -4.3% | +31.4% | -13.6% | +23.1% | -3.4% | -1.8% | +35.3% | +3.5% | +33.8% | +16.6% | -11.4% |